Brain Implants Market Size To Reach $11.19 Billion By 2030

Brain Implants Market Growth & Trends

The global brain implants market size is anticipated to reach USD 11.19 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.7% from 2023 to 2030. The rise in neurological disorders such as epilepsy, Parkinson’s disease, depression, and tremors as well as growing investments in R&D to develop cost-effective brain implants is attributing to the growth of the market.

The presence of a large population base suffering from various neurological and physiological disorders and conditions is expected to boost the demand for implants during the forecast period. For instance, as per the Parkinson’s Foundation 2016 report, over 10 million people globally are living with Parkinson’s disease (PD). Thus, the increasing cases of PD are expected to drive the market. However, the outbreak of the COVID-19 pandemic is restricting the growth of the market. For instance, as per the Neuromodulation Society of the U.K. and Ireland, in the U.K. all the NHS hospitals were instructed to suspend all the non-urgent elective surgeries due to the pandemic from 15^th April in 2020 for at least three months.

In addition, technological advancements such as self-charging implants and memory chips are anticipated to provide the market with growth opportunities over the forecast period. For instance, in January 2020, Abbott’s Infinity DBS received an extended indication approval from the U.S. FDA for PD treatment.

 Request a free sample copy or view report summary: Brain Implants Market Report

Brain Implants Market Report Highlights

• The deep brain stimulators segment accounted for the largest revenue share of 36.7% in 2022 attributed to its use in various applications in neurological disorders.

• The vagus nerve stimulator segment is expected to grow at the fastest CAGR of 10.1% during the forecast period owing to the factors such as applications in the treatment of various disorders such as anxiety, migraines, fibromyalgia, tinnitus, and obesity.

• The chronic pain segment accounted for the largest revenue share of 58.5% in 2022 owing to an increase in the incidence of chronic pain has created clinical urgency for incorporating long-term solutions.

• North America dominated the global brain implants market and accounted for the largest revenue share of 42.2% in 2022. This dominance can be attributed to factors such as an increase in the prevalence of neurological disorders, a rise in awareness about treatments, the availability of highly skilled physicians, and the presence of well-established healthcare facilities.

• Asia Pacific is expected to grow at the fastest CAGR of 10.9% over the forecast period owing to various factors such as the rising prevalence of neurodegenerative and psychiatric disorders, coupled with unmet need for effective and long-term treatment solutions, increasing affordability, and a rising number of awareness programs.

Brain Implants Market Segmentation

Grand View Research has segmented the global brain implants market on the basis of product, application, and region:

Brain Implants Product Outlook (Revenue, USD Million, 2018 - 2030)

• Deep Brain Stimulator

• Spinal Cord Stimulator

• Vagus Nerve Stimulator

Brain Implants Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Pain

• Epilepsy

• Parkinson’s 

• Depression

• Essential Tremor

• Alzheimer’s

Brain Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Mexico

  • Brazil

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Brain Implants Market

• Medtronic

• Boston Scientific Corporation

• St. Jude Medical (Abbott)

• NeuroPace, Inc.

• Nevro Corporation

• Synapse Biomedical Inc.

• ALEVA NEUROTHERAPEUTICS